Amanta Healthcare Limited has informed the stock exchanges that the audio recording of its earnings conference call for the quarter ended March 31, 2026 (Q4 FY26) is now available for access. The company stated that the recording has been uploaded to its official website.

The disclosure, addressed to the Senior General Managers of the Listing Departments at BSE Limited and the National Stock Exchange of India Limited, references the company's earlier intimation dated May 16, 2026. The audio file provides details regarding the financial performance and operational updates discussed during the conference call.

Investors and interested stakeholders can listen to the recording by visiting the dedicated investor relations section on the company's website. The specific link provided for accessing the audio is https://www.amanta.co.in/investor-meet .

The communication was signed by Nikhita Dinodia, the Company Secretary and Compliance Officer of Amanta Healthcare Limited. The intimation was submitted to the exchanges to ensure regulatory compliance and transparency for shareholders.

Key Details

Amanta Healthcare Limited has provided a clarification to stock exchanges regarding the completion of a share acquisition transaction by promoter Shri Bhavesh Patel. The company confirmed that the remaining portion of shares from an earlier acquisition has been successfully credited to the promoter's demat account.

Transaction Completion Details

The company clarified that 15,500 equity shares purchased on March 30, 2026, were credited to Shri Bhavesh Patel's demat account on April 17, 2026. This represents the completion of a larger transaction involving 28,800 equity shares, for which the company had provided initial intimation to stock exchanges on April 1, 2026.

The clarification follows an earlier communication dated April 18, 2026, regarding the credit of 13,300 equity shares to the same promoter's demat account, indicating that the transaction was completed in two separate tranches.

Revised Shareholding Position

Following the complete transaction, the company has provided updated details of the promoter's shareholding position:

The acquisition represents a marginal increase of 0.04% in the promoter's voting capital, bringing the total shareholding to 16.29% from the previous 16.25%.

Regulatory Compliance

Amanta Healthcare has requested both BSE Limited and National Stock Exchange of India Limited to take this clarification on record and replace the earlier intimation with the revised information. This ensures accurate reflection of the promoter's shareholding position in the exchange records.

The company's communication, signed by Company Secretary and Compliance Officer Nikhita Dinodia, demonstrates adherence to regulatory disclosure requirements for promoter share transactions. The clarification provides transparency regarding the timing and completion of the share credit process, ensuring all stakeholders have accurate information about the promoter's current shareholding status.